Inside pics of all the luxurious private jets owned by Serum Institute of India CEO Adar Poonawalla - SII CEO Adar Poonawalla lives in a sprawling 247-acre property, which is designed by Sussanne Khan.
Serum Institute of India Chief Executive Officer Adar Poonawalla. | Adar Poonawalla/ Twitter
Serum Institute of India Chief Executive officer Adar Poonawalla on Saturday said that he will be returning to India, hours after his interview published in
The Times noted that he had left the country because of threats related to the delivery of Covid-19 vaccines.
Poonawalla is chief executive officer of the Serum Institute, the local maker of the Covid-19 vaccine, Covishield, developed by Oxford University and pharmaceutical company AstraZeneca.
In the interview to the British daily, Poonawalla said that he was under pressure for the delivery of Covid-19 vaccines as its demand was constantly increasing. “I don’t want to be in a situation where you are just trying to do your job, and just because you can’t supply the needs of X, Y or Z you really don’t want to guess what they are going to do,” he said.
COVID-19 Vaccine: Adar Poonawalla s Serum Institute is the world s biggest vaccine manufacturer.
New Delhi:
Adar Poonawalla, CEO of the Serum Institute, the world s largest vaccine manufacturer by volume, this morning urged nations to be patient amid the wait for Covishield, the coronavirus vaccine that the SII has developed in partnership with the Oxford University and British-Swedish pharma firm AstraZeneca. Dear countries & governments, as you await #COVISHIELD supplies, I humbly request you to please be patient, @SerumInstIndia has been directed to prioritise the huge needs of India and along with that balance the needs of the rest of the world. We are trying our best (sic), Mr Poonawalla tweeted this morning.
Covishield is ready for roll-out in the coming weeks , said Adar Poonawalla. (File photo)
New Delhi:
All the risks taken by Serum Institute have finally paid off, tweeted Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, shortly after the country s drug regulator cleared its Covishield vaccine for emergency approval in India. Mr Poonawalla reiterated that the Covishield vaccine developed by Serum Institute of India in partnership with the Oxford University and pharma major AstraZeneca - is safe and effective against coronavirus and added that the vaccine is ready to roll out in the coming weeks .
Mr Poonawalla, CEO of the Serum Institute, said to be the world s largest vaccine maker, had earlier said the majority of the first 50 million doses will go to India .